[1]CurrentPatentAssignee:GTCRLLC-US2009/88447,2009,A1Locationinpatent:Page/Pagecolumn8
[1]CurrentPatentAssignee:GTCRLLC-US2009/88447,2009,A1Locationinpatent:Page/Pagecolumn8
Title: Telotristat ethyl: a new option for the management of carcinoid syndrome.
Journal: Expert opinion on pharmacotherapy 20161201
Title: Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20150915
Title: Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
Journal: Endocrine-related cancer 20141001
Title: Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
Journal: Gut 20140601
Title: Tamas Oravecz, et al. LX1606 (aka LX1032), a Novel Inhibitor of Serotonin Synthesis, Alleviates Development of Inflammatory Bowel Disease in a Preclinical Model.
Title: Margolis, K.G., et al., Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut, 2013.
